EPIMATE

This brand name is authorized in Nigeria. It is also authorized in South Africa.

Active ingredients

The drug EPIMATE contains one active pharmaceutical ingredient (API):

1	Topiramate UNII 0H73WJJ391 - TOPIRAMATE
	Topiramate is classified as a sulfamate-substituted monosaccharide. The precise mechanism by which topiramate exerts its antiseizure and migraine prophylaxis effects are unknown.
	Read more about Topiramate

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2509	Tablet	Epimate 100 Tablets TAB 100 mg		28/10/2021
B4-2510	Tablet	Epimate 25 Tablets TAB 25 mg		28/10/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AX11	Topiramate	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2509, B4-2510
ZA	Health Products Regulatory Authority	43/2.5/0823, 43/2.5/0824, 43/2.5/0825, 43/2.5/0826